Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)

NCT00483106 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT00483106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00483106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
Lead sponsor
McGill University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 1999
Completion date
March 31, 2020
Enrollment
885 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder